American Journal of Cardiovascular Drugs

ACE Inhibition in Hypertension: Focus on Perindopril
pp. 303-317(15)
Author: Cockcroft, John R.

Defining the Role of Repaglinide in the Management of Type 2 Diabetes Mellitus: A Review
pp. 319-335(17)
Authors: Odd Erik Johansen,; Birkeland, Kåre I.

The Tragedy of TRIUMPH for Nitric Oxide Synthesis Inhibition in Cardiogenic Shock: Where Do We Go from Here?
pp. 337-345(9)
Authors: Bailey, Alison; Pope, Theodore W.; Moore, Scott A.; Campbell, Charles L.

Dose-Response Characteristics of Olmesartan Medoxomil and Other Angiotensin Receptor Antagonists
pp. 347-356(10)
Author: Smith, David H.G.

Flaws in Dose-Finding of Antihypertensive Drugs
pp. 357-359(3)
Author: Stergiou, George S.

Efficacy and Safety of Olmesartan Medoxomil and Hydrochlorothiazide Compared with Benazepril and Amlodipine Besylate
pp. 361-372(12)
Authors: Kereiakes, Dean J.; Neutel, Joel M.; Punzi, Henry A.; Xu, Jianbo; Lipka, Leslie J.; Dubiel, Robert

Effects of ACE Inhibitors or β-Blockers in Patients Treated with the Fixed-Dose Combination of Isosorbide Dinitrate/Hydralazine in the African-American Heart Failure Trial
pp. 373-380(8)
Authors: Ghali, Jalal K.; Tam, S. William; Ferdinand, Keith C.; Lindenfeld, JoAnn; Sabolinski, Michael L.; Taylor, Anne L.; Worcel, Manuel; Curry, Charles L.; Cohn, Jay N.; Investigators, the A-HeFT

Treatment and Control of BP and Lipids in Patients with Hypertension and Additional Risk Factors
pp. 381-389(9)
Authors: Welch, Verna; Tang, Simon S.K.